Author:
Regev Arie,Seeff Leonard B.,Merz Michael,Ormarsdottir Sif,Aithal Guruprasad P.,Gallivan Jim,Watkins Paul B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference38 articles.
1. Chitturi S, Farrell GC. Drug induced liver disease. In: Schiff ER, et al., editors. Schiff’s diseases of the liver. 11th ed. New York: Wiley-Blackwell; 2012. p. 703–82.
2. FDA. Drug-induced livery injury: premarketing clinical evaluation. In: Guidance for industry. 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM174090.pdf . Accessed 21 January 2013.
3. Health Canada. Guidance document: pre-market evaluation of hepatotoxicity in health products. 2012. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/hepatotox_guide_ld-eng.php . Accessed 13 February 2012.
4. Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806–15.
5. Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: applications to drug induced liver injury. J Clin Epidemiol. 1993;46:1323–30.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献